• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER Back to Search Results
Catalog Number ASD37E
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Migration (4003)
Patient Problems Obstruction/Occlusion (2422); Foreign Body Embolism (4439)
Event Date 03/23/2022
Event Type  Injury  
Manufacturer Narrative
Patient identifiers-initials, dob/age, weight, requested but not available.The gore case number 00008317 is being used as patient identifier.Imaging evaluation: the device was positioned well and it appeared to be in a stable but not locked position.However, without additional imaging this cannot be confirmed.It was reported that after locking and releasing the device, the physician noted that the locking loop was still constrained in the control catheter.This is typical in a delayed lock release.Prior to releasing the device, rocking the handle back and forth can help release the locking loop from the control catheter.Additionally, loosening the delivery catheter at the luer lock and advancing it over the grey control catheter to the right atrial eyelet and slightly pushing the device can help release the locking loop from the control catheter.The retrieval cord was released prior to trying these measures causing the device to become unstable when advancing the delivery catheter over the grey control catheter.They device became dislodged and ended up in the pulmonary artery.A loop snare was then advanced to retrieve the device.The device was retrieved and per the performing facility, the patient was sent for surgical repair of the defect.The gore® cardioform asd occluder instructions for use states: potential clinical and device adverse events associated with the use of the occluder may include, but are not limited to: device embolization.
 
Event Description
It was reported to gore a 37mm gore® cardioform asd occluder was selected to treat an atrial septal defect measuring 21mm by balloon sizing with deficient aortic rim.The device was aligned nicely on the septum and no residual shunt was detected.The device was locked and released.After removing the retrieval cord the physician noticed that the locking loop was still inside the catheter, therefore, he opened the luer lock and advanced the trans-septal sheath to the left and pulled on the handle.During this maneuver, the device embolized into the pulmonary artery and had to be snared.The patient was sent for surgical closure of the defect.
 
Manufacturer Narrative
H6: added type of investigation codes 4112 and 4117.Added conclusion code 22.
 
Manufacturer Narrative
B3: added additional information.H6: added type of investigation code 4111.Added investigation findings code 3207.Added investigation conclusion code 50.Patient identifiers, initials, dob/age, and weight were requested but not provided.H6: health effect clinical code changed to 4439.Medical device problem code changed to 4003.
 
Event Description
It was reported to gore a 37mm gore® cardioform asd occluder was selected to treat an atrial septal defect measuring 21mm by balloon sizing with deficient aortic rim.The device was aligned nicely on the septum and no residual shunt was detected.The device was locked and released.After removing the retrieval cord the physician noticed that the locking loop was still inside the catheter, therefore, he opened the luer lock and advanced the trans-septal sheath to the left and pulled on the handle.During this maneuver, the device embolized into the pulmonary artery and had to be snared.The patient was sent for surgical closure of the defect.Received additional information that the physician indicated the patients anatomy was the most likely cause of the device embolizing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM ASD OCCLUDER
Type of Device
TRANSCATHETER, SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
kathy titus
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key13968491
MDR Text Key288315628
Report Number2017233-2022-02836
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/05/2023
Device Catalogue NumberASD37E
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/23/2022
Initial Date FDA Received03/31/2022
Supplement Dates Manufacturer Received03/23/2022
03/23/2022
Supplement Dates FDA Received04/14/2022
04/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/05/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient SexFemale
-
-